797 related articles for article (PubMed ID: 10851052)
21. Janus kinases: components of multiple signaling pathways.
Rane SG; Reddy EP
Oncogene; 2000 Nov; 19(49):5662-79. PubMed ID: 11114747
[TBL] [Abstract][Full Text] [Related]
22. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs.
Chaturvedi P; Sharma S; Reddy EP
Mol Cell Biol; 1997 Jun; 17(6):3295-304. PubMed ID: 9154828
[TBL] [Abstract][Full Text] [Related]
23. The role of STATs in transcriptional control and their impact on cellular function.
Bromberg J; Darnell JE
Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
[TBL] [Abstract][Full Text] [Related]
24. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
25. Jaks and Stats in signaling by the cytokine receptor superfamily.
Ihle JN; Kerr IM
Trends Genet; 1995 Feb; 11(2):69-74. PubMed ID: 7716810
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic cytokine receptor signaling.
Baker SJ; Rane SG; Reddy EP
Oncogene; 2007 Oct; 26(47):6724-37. PubMed ID: 17934481
[TBL] [Abstract][Full Text] [Related]
27. Signaling through the JAK/STAT pathway, recent advances and future challenges.
Kisseleva T; Bhattacharya S; Braunstein J; Schindler CW
Gene; 2002 Feb; 285(1-2):1-24. PubMed ID: 12039028
[TBL] [Abstract][Full Text] [Related]
28. Regulation of STAT-dependent pathways by growth factors and cytokines.
Leaman DW; Leung S; Li X; Stark GR
FASEB J; 1996 Dec; 10(14):1578-88. PubMed ID: 9002549
[TBL] [Abstract][Full Text] [Related]
29. Janus kinases in cytokine signalling.
Ihle JN
Philos Trans R Soc Lond B Biol Sci; 1996 Feb; 351(1336):159-66. PubMed ID: 8650262
[TBL] [Abstract][Full Text] [Related]
30. Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) in hematopoietic cells.
Nosaka T; Kitamura T
Int J Hematol; 2000 Jun; 71(4):309-19. PubMed ID: 10905049
[TBL] [Abstract][Full Text] [Related]
31. IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells.
Kopantzev Y; Heller M; Swaminathan N; Rudikoff S
Oncogene; 2002 Oct; 21(44):6791-800. PubMed ID: 12360405
[TBL] [Abstract][Full Text] [Related]
32. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
Yu WM; Hawley TS; Hawley RG; Qu CK
Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
34. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes.
Andl CD; Mizushima T; Oyama K; Bowser M; Nakagawa H; Rustgi AK
Am J Physiol Gastrointest Liver Physiol; 2004 Dec; 287(6):G1227-37. PubMed ID: 15284024
[TBL] [Abstract][Full Text] [Related]
35. Unexpected transcriptional signals in normal and mitotically defective cells mediated through cytokine and growth factor receptors.
Samanta A; Qian X; Greene MI
DNA Cell Biol; 1995 Nov; 14(11):921-30. PubMed ID: 7576178
[TBL] [Abstract][Full Text] [Related]
36. In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2.
Flores-Morales A; Pircher TJ; Silvennoinen O; Gustafsson JA; Sanchez-Gomez M; Norstedt G; Haldosén LA; Wood TJ
Mol Cell Endocrinol; 1998 Mar; 138(1-2):1-10. PubMed ID: 9685210
[TBL] [Abstract][Full Text] [Related]
37. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation.
Bellido T; Borba VZ; Roberson P; Manolagas SC
Endocrinology; 1997 Sep; 138(9):3666-76. PubMed ID: 9275051
[TBL] [Abstract][Full Text] [Related]
38. Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation.
Wang L; Rudert WA; Loutaev I; Roginskaya V; Corey SJ
Oncogene; 2002 Aug; 21(34):5346-55. PubMed ID: 12149655
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors.
Callus BA; Mathey-Prevot B
Blood; 1998 May; 91(9):3182-92. PubMed ID: 9558373
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways.
Sengupta TK; Schmitt EM; Ivashkiv LB
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9499-504. PubMed ID: 8790359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]